These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36757449)

  • 1. Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain.
    Schreyer KF; Leucht S; Heres S; Steimer W
    Psychopharmacology (Berl); 2023 Apr; 240(4):899-908. PubMed ID: 36757449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.
    Czerwensky F; Leucht S; Steimer W
    J Clin Psychopharmacol; 2013 Feb; 33(1):74-9. PubMed ID: 23277235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).
    Ter Hark SE; Jamain S; Schijven D; Lin BD; Bakker MK; Boland-Auge A; Deleuze JF; Troudet R; Malhotra AK; Gülöksüz S; Vinkers CH; Ebdrup BH; Kahn RS; Leboyer M; Luykx JJ
    J Psychopharmacol; 2020 May; 34(5):524-531. PubMed ID: 32126890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.
    Malhotra AK; Correll CU; Chowdhury NI; Müller DJ; Gregersen PK; Lee AT; Tiwari AK; Kane JM; Fleischhacker WW; Kahn RS; Ophoff RA; Meltzer HY; Lencz T; Kennedy JL
    Arch Gen Psychiatry; 2012 Sep; 69(9):904-12. PubMed ID: 22566560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?
    Czerwensky F; Leucht S; Steimer W
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2103-9. PubMed ID: 23920449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort).
    Pandit R; Cianci D; Ter Hark SE; Winter-van Rossum I; Ebdrup BH; Broberg BV; Garcia-Portilla MP; Bobes J; Vinkers CH; Kahn RS; Guloksuz S; Huitema ADR; Luykx JJ
    Acta Psychiatr Scand; 2019 Sep; 140(3):283-290. PubMed ID: 31323113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.
    Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ
    Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.
    Chowdhury NI; Tiwari AK; Souza RP; Zai CC; Shaikh SA; Chen S; Liu F; Lieberman JA; Meltzer HY; Malhotra AK; Kennedy JL; Müller DJ
    Pharmacogenomics J; 2013 Jun; 13(3):272-9. PubMed ID: 22310352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of orexin receptor polymorphisms with antipsychotic-induced weight gain.
    Tiwari AK; Brandl EJ; Zai CC; Goncalves VF; Chowdhury NI; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    World J Biol Psychiatry; 2016 Apr; 17(3):221-9. PubMed ID: 26447462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
    Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
    Newcomer JW
    CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
    Kahn RS; Winter van Rossum I; Leucht S; McGuire P; Lewis SW; Leboyer M; Arango C; Dazzan P; Drake R; Heres S; Díaz-Caneja CM; Rujescu D; Weiser M; Galderisi S; Glenthøj B; Eijkemans MJC; Fleischhacker WW; Kapur S; Sommer IE;
    Lancet Psychiatry; 2018 Oct; 5(10):797-807. PubMed ID: 30115598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.
    Yu H; Wang L; Lv L; Ma C; Du B; Lu T; Jin C; Yan H; Yang Y; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Mowry B; Ma W; Li K; Zhang D; Yue W
    Schizophr Bull; 2016 May; 42(3):814-23. PubMed ID: 26656879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A2BP1 gene polymorphisms association with olanzapine-induced weight gain.
    Dong L; Yan H; Huang X; Hu X; Yang Y; Ma C; Du B; Lu T; Jin C; Wang L; Yu H; Dong Z; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Ma W; Li K; Lv L; Zhang D; Yue W
    Pharmacol Res; 2015 Sep; 99():155-61. PubMed ID: 26092620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
    Johnsen E; Kroken RA; Løberg EM; Rettenbacher M; Joa I; Larsen TK; Reitan SK; Walla B; Alisauskiene R; Anda LG; Bartz-Johannessen C; Berle JØ; Bjarke J; Fathian F; Hugdahl K; Kjelby E; Sinkeviciute I; Skrede S; Stabell L; Steen VM; Fleischhacker WW
    Lancet Psychiatry; 2020 Nov; 7(11):945-954. PubMed ID: 33069317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.